Supermax Corporation

SUPERMX

MYL7106OO007

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
0.83 ^MYR	+0.61%		+0.61%	-11.70%

Apr. 23	Supermax Corporation Berhad commences an Equity Buyback Plan, under the authorization approved on December 8, 2023.	CI
Feb. 20	Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Supermax Corporation Berhad Appoints Miss Sung Fong Fui as Independent and Non Executive Director, Effective from December 08, 2021

November 17, 2021 at 07:32 am EST

Supermax Corporation Berhad appointed Miss Sung Fong Fui as Independent and Non Executive Director, effective from December 08, 2021.

Latest news about Supermax Corporation

Supermax Corporation Berhad commences an Equity Buyback Plan, under the authorization approved on December 8, 2023.	Apr. 23	CI
Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 20	CI
Supermax Names CEO, COO	Dec. 20	MT
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024	Dec. 19	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024	Dec. 19	CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok, as Independent and Non Executive Member of Risk Committee, Effective 02 Jan 2024	Dec. 19	CI
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Re-Designation of Tan Chee Keong as Senior Executive Director from Executive Director. Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Gan Kim Khoon as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Wong Phait Lee as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Resignation of Puan Rozita Binti Abdul Rahman as Independent and Non Executive Member of Audit Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Gan Kim Khoon as Independent and Non Executive Member of Audit Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Wong Phait Lee as Independent and Non Executive Member of Audit Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Re-Designation of Tan Chee Keong as Chief Executive Officer from Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Mr. Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective on January 02, 2024	Dec. 18	CI
Supermax Corporation Bhd Appoints Tan Chee Keong or CK Tan as its Senior Executive Director Effective January 2, 2024	Dec. 17	CI
Supermax Corporation Bhd Appoints Tan Chee Keong or CK Tan as Chief Executive Officer, Effective January 2, 2024	Dec. 17	CI
Supermax's First Manufacturing Facility in Texas Nears Completion	Dec. 10	MT
Supermax Corporation Berhad Announces Cessation of Miss Tan Poh Chan as Independent and Non Executive Chairman of Risk Committee	Dec. 08	CI
Supermax Corporation Berhad Announces Retirement of Miss TAN POH CHAN as Independent and Non Executive Director	Dec. 08	CI
Supermax Corporation Berhad Announces Cessation of Miss TAN POH CHAN as Independent and Non Executive and Member of Audit Committee	Dec. 08	CI
Supermax Corporation Berhad's Equity Buyback announced on April 19, 2023, has expired.	Dec. 07	CI

Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. The Company operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. The Company is an international manufacturer, distributor, and marketer of medical gloves. It manufactures various types of nitrile latex and natural rubber gloves, which are exported to over 165 countries around the world, such as the United States of America, European Union, Middle East, Asia, and South Pacific countries. The Company owns a range of brands, such as Supermax, Aurelia and Maxter, which are used by laboratories, hospitals, pharmacists, doctors, and surgeons throughout the world. It produces over 26 billion pieces of gloves per year. It has approximately eight distribution centres based in the United States of America, Brazil, Canada, Germany, Hong Kong, and United Kingdom.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Supermax Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.83 MYR

Average target price

0.9633 MYR

Spread / Average Target

+16.06%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
SUPERMAX CORPORATION	-11.70%	447M
COLOPLAST A/S	+18.26%	29.7B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-33.64%	2.9B
WINNER MEDICAL CO., LTD.	-9.29%	2.71B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+2.61%	2.14B
HARTALEGA HOLDINGS	-0.74%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.01%	1.84B
TOP GLOVE CORPORATION BHD.	-5.56%	1.42B
NAKANISHI INC.	-2.49%	1.26B
KANGJI MEDICAL HOLDINGS LIMITED	+3.72%	1.13B

Medical Supplies